Tumor uptake was three-fold higher for 64Cu-cunotadipep than 64Cu-cudotadipep, similar to the results of the in vitro experiment; the tumor uptake of 64Cu-cunotadipep appeared to have increased because of the high PSMA affinity. The gene discussed is FOLH1; the disease is neoplasm.